amg 176
Small moleculeexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jun 13, 2016 (NCT02675452)
Timeline
2010s
- Jan 1, 2016
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- amg 176
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05209152 | Phase 1 | Nov 15, 2022 | Amgen |
| NCT03797261 | Phase 1 | Mar 15, 2019 | AbbVie, Amgen, Genentech |
| NCT02675452 | Phase 1 | Jun 13, 2016 | Amgen |
Showing 3 of 3 trials
Page 1 / 1